Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 1/25/07  and contains information from public web pages.

Dr. Andrea N. Meyerhoff

Wrong Dr. Andrea N. Meyerhoff?
 
Background

Employment History

Board Memberships and Affiliations

  • Director
    WMD Defense for the Department of Defense

Education

  • M.D.
25 Total References
Web References
Red Book® Online -- Committee 2000
aapredbook.aappublications.org, 25 Jan 2007 [cached]
Andrea Meyerhoff, MD, Food and Drug Administration, Bethesda, MD
U.S. Medicine Information Central
www.usmedicine.com, 22 April 2006 [cached]
"We take a comprehensive view of food and water safety," said Dr. Andrea Meyerhoff, director of anti-terrorism programs in FDA's Office of the Commissioner.
Anthrax articles from the Hartford Courant
www.anthraxinvestigation.com, 19 Dec 2001 [cached]
His comments were echoed in December 2005 by Andrea Meyerhoff, former director of WMD Defense for the Department of Defense and former director of counterterrorism for the FDA.
"We must take steps to avoid the potential for flawed decisions because unproven countermeasures can be a waste of taxpayers' money, and worse, may not be safe and effective," Meyerhoff said.
Specialists call for testing of anthrax drug
www.cmonitor.com, 20 Nov 2001 [cached]
"The preliminary information available is promising, but it has not been studied in an animal model," said Andrea Meyerhoff, the FDA's bioterrorism director.
But the agency doesn't prevent doctors from using any drug for purposes other than those FDA specifically approves, she said.
Last month, Johnson & Johnson and other drug companies with products in the same antibiotic class as Cipro offered to donate massive supplies to the national pharmaceutical stockpile in the event of a large-scale anthrax emergency.To accept that offer, however, federal officials would have to grant the company's request that Levaquin be approved as an anthrax drug; so far, they have not.
No health officials have suggested Levaquin was an inappropriate treatment.Several attending physicians said they initially believed they were treating pneumonia, and many infectious disease specialists regard Levaquin as the best choice for that.
Regulatory Affairs Professionals Society
www.raps.org [cached]
A Conversation with Dr. Andrea Meyerhoff, Director of Antiterrorism Programs, Office of the Commissioner, FDA
Other People with the name "Meyerhoff":
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304